GTR Home > Conditions/Phenotypes > Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency


Cardioencephalomyopathy due to cytochrome c oxidase deficiency is an autosomal recessive mitochondrial disorder characterized by onset of cardiomyopathy either in utero or in the first days of life. Most patients also show neurologic abnormalities, such as abnormal breathing pattern, nystagmus, and gyral abnormalities, consistent with encephalopathy. The disorder is usually fatal in early infancy (summary by Papadopoulou et al., 1999). Genetic Heterogeneity of Fatal Infantile Cardioencephalomyopathy Due to Cytochrome c Oxidase Deficiency See also CEMCOX2 (615119), caused by mutation in the COX15 gene (603646) on chromosome 10q24; CEMCOX3 (616500), caused by mutation in the COA5 gene (613920) on chromosome 2q11; and CEMCOX4 (616501), caused by mutation in the COA6 gene (614772) on chromosome 1q42. For a phenotypic description and a discussion of genetic heterogeneity of cytochrome c oxidase deficiency, see 220110. [from OMIM]

Available tests

41 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Genes See tests for all associated and related genes

  • Also known as: CEMCOX1, ECGF1, Gliostatin, MYP6, PD-ECGF, SCO1L, TP, TYMP, TdRPase, SCO2
    Summary: SCO cytochrome c oxidase assembly protein 2

Clinical features


Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center